Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
FLGT.US
id: 302
C.D. California
Court
On August 4, 2022, Fulgent disclosed that the SEC was conducting an investigation into certain of the Company’s reports filed with the SEC from 2018 through Q1 2020.

Earlier Fulgent received a civil investigative demand issued by the U.S. Department of Justice “related to its investigation of allegations of medically unnecessary laboratory testing, improper billing for laboratory testing, and remuneration received or provided in violation of the Anti-Kickback Statute and the Stark Law.”

On this news, Fulgent’s stock price declined over 21% through the next 3 trading days, seriously damaging investors.
Alleged Offence
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Suspected Party
Directors
Management
Service Provider
Security Type
Stocks
Trade Direction
Long
Shock Event Date
04 August 2022
Collecting participants…

Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The c...

    Ticker
    FLGT.US
    ISIN
    US3596641098
    CIK
    1674930
    Sector
    Healthcare
    Industry
    Diagnostics & Research
    Country
    USA
    Address
    4399 Santa Anita Avenue, El Monte, CA, United States, 91731